Tandem Diabetes Care Announces t:slim X2 Integration with Dexcom G7
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leader in the diabetes management technology space, has exciting news for t:slim X2 insulin pump users. A recent collaboration with Dexcom has led to a significant advancement: the t:slim X2 insulin pump is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems in Canada.
Enhancing Diabetes Management with Cutting-Edge Technology
The t:slim X2 insulin pump is esteemed for its Control-IQ technology, which has earned the title of the top-rated automated insulin delivery (AID) system. This integration means that Canadians using the t:slim X2 can now enjoy the benefits of the cutting-edge Dexcom G7, offering a streamlined experience for insulin management.
Partnership with Dexcom
Mark Novara, Tandem Diabetes Care's Executive Vice President, emphasized the importance of this integration, highlighting their long-standing partnership with Dexcom. “This commercial availability truly reflects our shared values in advancing automated insulin delivery systems,” he remarked. The availability of these sophisticated tools allows users to manage their diabetes with ease and enhance their quality of life.
New Features for Users
With the launch of the t:slim X2 pump featuring Dexcom G7 integration in Canada, users will benefit from improved CGM compatibility. Among the standout features of the Dexcom G7 is its rapid sensor warm-up time, which allows users to begin monitoring glucose levels within just 30 minutes - faster than other CGM solutions available.
Streamlined Usage with Apple Smartwatch
An exciting enhancement for Apple users is the ability to view their glucose data directly on their smartwatches. By pairing the t:slim X2 with the Dexcom G7 and an Apple smartwatch, users can to access vital glucose numbers without needing to check their insulin pump or smartphone constantly.
Getting Started with the New Compatibility
For current t:slim X2 users in warranty, Tandem will send instructions via email on how to activate the new compatibility feature at no additional cost. This will be done through a simple remote software update. Additionally, pumps equipped with the updated software are scheduled to ship to new customers starting early 2025.
Future of Diabetes Care
Tandem Diabetes Care continues to focus on innovation and ensuring accessibility for patients. Those interested in acquiring a Tandem insulin pump can check detailed coverage information and begin their process through the official Tandem Diabetes Care Canada website.
A Commitment to Innovation
While the t:slim X2 insulin pump with Control-IQ technology is a remarkable achievement for diabetes care, the journey towards advanced insulin management solutions is ongoing. Tandem remains focused on enhancing and creating new technologies to empower users in their daily management of diabetes.
Frequently Asked Questions
What is the main benefit of the new t:slim X2 integration with Dexcom G7?
The integration allows users to access advanced features, such as quicker sensor warm-up times and seamless connectivity to Apple smartwatches for glucose monitoring.
Will there be any costs associated with the software update?
No, the software update to enable compatibility is provided free of charge to all in-warranty t:slim X2 users.
When will new t:slim X2 pumps be available for purchase?
New customers can expect to receive t:slim X2 pumps with updated software beginning in early January 2025.
Are there benefits to using Dexcom G6 with t:slim X2?
Yes, users can still enjoy comprehensive features and continuous glucose monitoring with the Dexcom G6 system alongside the t:slim X2 pump.
How can I learn more about Tandem Diabetes Care products?
For more information, individuals are encouraged to visit the Tandem Diabetes Care Canada website for the latest updates and available products.
